sample

Background: Medical progress and the lifestyle modification have prolonged life expectancy, despite the development of...

Posté par : Mme. Astrid POZET, Pr. Franck BONNETAIN
Nom de la revue : Trials

sample

AbstractBackground: Frailty is highly prevalent in elderly people. While significant progress has been made to...

Posté par : Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, Mme. Astrid POZET, Pr. Franck BONNETAIN
Nom de la revue : BMC Geriatrics

sample

AbstractBackground: Pancreatic adenocarcinoma (PDAC) incidence is increasing worldwide. Several studies have shown...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : BMC Cancer

sample

Docetaxel, cisplatin, and 5-fluorouracil (DCF) significantly improved overall survival in metastatic gastroesophageal...

Posté par : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY
Nom de la revue : Cancer Medecine

sample

Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : Lancet Oncology

sample

AbstractTemozolomide (TEM) showed encouraging results in well-differentiated pancreatic neuroendocrine tumors (WDPNETs)....

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Endocrine-Related Cancer

sample

AbstractThe diagnosis system for allograft loss lacks accurate individual risk stratification on the basis of...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : J Am Soc Nephrol

sample

In first-line metastatic colorectal cancer (mCRC), baseline prognostic factors allowing death risk and treatment...

Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : International Journal of Cancer

sample

Background: The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better...

Posté par : Dr. Dewi VERNEREY, Dr. Angélique VIENOT, Pr. Franck BONNETAIN
Nom de la revue : British Journal of Cancer

sample

Our aim was to review the studies which assessed potential surrogate endpoints for overall survival (OS) in breast...

Posté par : Pr. Franck BONNETAIN,
Nom de la revue : Breast

sample

In the Intergroupe Francophone de Cancérologie Thoracique 0501 trial the carboplatinpaclitaxel chemotherapy increased...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : European Respiratory Journal

sample

Background: Even though the perioperative chemotherapy improves the overall survival (OS) compared to surgery alone in...

Posté par : Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Nom de la revue : European Journal of Surgical Oncology

sample

PurposeWe previously showed that a sequential chemotherapy with dose-dense oxaliplatin (FOLFOX7)and irinotecan (FOLFIRI;...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : PLOS ONE

sample

AbstractGlioblastoma is the most common malignant brain tumor in adults. Baselinehealth-relatedquality of life (HRQoL)...

Posté par : , Dr. Dewi VERNEREY, , Pr. Franck BONNETAIN
Nom de la revue : Cancer Medicine

sample

OBJECTIVES: The objective of this study was to explore the association between health-related quality of life (HRQoL)...

Posté par : , Pr. Franck BONNETAIN
Nom de la revue : BMJ Open

OBJECTIVES: We conducted a prospective study approved by the local ethics committee to determine the impact of a...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : Annales pharmaceutiques françaises

sample

IMPORTANCE In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : JAMA

sample

Health-related quality of life (HRQOL) in cancer research is critical to more comprehensively evaluate patients’...

Posté par : Pr. Franck BONNETAIN, ,
Nom de la revue : Journal of Clinical Oncology

sample

AbstractBackground: Health-related quality of life (HRQoL) is recognized as a component endpoint for cancer...

Posté par : Pr. Franck BONNETAIN
Nom de la revue : BMC Cancer

2015-2022 © Copyright - UMQVC.org

Website by Pearlweb